Clinical trials
Completed Chagas Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 9 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 6 |
| Hospital Sao Rafael | 6 |
| Drugs for Neglected Diseases | 4 |
| Hospital de Niños R. Gutierrez de Buenos Aires | 4 |
| Barcelona Centre for International Health Research | 2 |
| Evandro Chagas National Institute of Infectious Disease | 2 |
| Federal University of Minas Gerais | 2 |
| Hospital Universitari Vall d'Hebron Research Institute | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chagas Disease | 50 |
| Chagas Cardiomyopathy | 7 |
| Heart Diseases | 4 |
| Heart Failure | 4 |
| Cardiomyopathies | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Hepatitis B | 2 |
| Hepatitis C | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arrhythmias, Cardiac | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.